Article Versions Notes

Marcos S, Albiñana V, Recio-Poveda L, Tarazona B, Verde-González MP, Ojeda-Fernández L, Botella L-M. SARS-CoV-2 Infection in Hereditary Hemorrhagic Telangiectasia Patients Suggests Less Clinical Impact Than in the General Population. Journal of Clinical Medicine. 2021; 10(9):1884. https://doi.org/10.3390/jcm10091884

Marcos, Sol, Virginia Albiñana, Lucia Recio-Poveda, Belisa Tarazona, María Patrocinio Verde-González, Luisa Ojeda-Fernández, and Luisa-María Botella. 2021. "SARS-CoV-2 Infection in Hereditary Hemorrhagic Telangiectasia Patients Suggests Less Clinical Impact Than in the General Population" Journal of Clinical Medicine 10, no. 9: 1884. https://doi.org/10.3390/jcm10091884

Marcos, S., Albiñana, V., Recio-Poveda, L., Tarazona, B., Verde-González, M. P., Ojeda-Fernández, L., & Botella, L.-M. (2021). SARS-CoV-2 Infection in Hereditary Hemorrhagic Telangiectasia Patients Suggests Less Clinical Impact Than in the General Population. Journal of Clinical Medicine, 10(9), 1884. https://doi.org/10.3390/jcm10091884